Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia
- 1 February 1993
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 46 (2) , 151-163
- https://doi.org/10.1016/0165-1781(93)90017-b
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Changes in Plasma Homovanillic Acid Concentrations in Schizophrenic Patients Following Neuroleptic DiscontinuationArchives of General Psychiatry, 1991
- Plasma catecholamine metabolites in Schizophrenics: Evidence for the two-subtype conceptBiological Psychiatry, 1990
- Plasma catecholamine metabolites and treatment response at neuroleptic steady stateBiological Psychiatry, 1989
- Plasma Homovanillic Acid as a Predictor of Response to NeurolepticsArchives of General Psychiatry, 1988
- Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patientsNeuropsychopharmacology, 1987
- Control of exogenous factors affecting plasma homovanillic acid concentrationPsychiatry Research, 1987
- In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: Implications for drug mechanisms of actionLife Sciences, 1986
- Antipsychotic Drug Action in Schizophrenic Patients: Effect on Cortical Dopamine Metabolism After Long-Term TreatmentScience, 1979
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976